V

Valion Bio Inc.
D

VBIO

1.44500
USD
-0.11
(-6.77%)
قبل الجلسة·1.57000USD+0.12500(+8.65%)
حجم التداول
1,022
الربح لكل سهم
-24
العائد الربحي
-
P/E
-0
حجم السوق
1,282,566

العنوان: Valion Bio Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.